Clinical Trials for Pancreatic Ductal Adenocarcinoma

Find clinical trials for pancreatic ductal adenocarcinoma. Discover research opportunities and treatment options in your area.

94 Active Trials Found

Showing 94 trials on this page

Page 2 of 5

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT ID: NCT05783622

This clinical trial is studying a new treatment called JANX008 for adults with advanced or metastatic solid tumors, such as certain types of lung cancer, kidney cancer, and breast cancer. The aim i...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, St. Louis, Missouri, United States +16 more

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

NCT ID: NCT06287749

The FRENCH.MRD.PDAC trial is studying a type of blood test called a liquid biopsy to see if it can help doctors predict the risk of pancreatic cancer returning after treatment. Specifically, resear...

Recruiting

Type: observational Locations: Montpellier, , France

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

NCT ID: NCT05983133

This clinical trial is investigating a new drug called SGN-EGFRd2, aimed at treating patients with advanced solid tumors, including certain types of colorectal cancer, lung cancer, and pancreatic c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, Tampa, Florida, United States +33 more

Reinforced Pancreaticojejunostomy With or Without glubran2

NCT ID: NCT06756074

This clinical trial is studying a surgical technique called reinforced pancreaticojejunostomy with or without a special tissue glue called Glubran2. The goal is to find out which method works best ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Minya, Minia, Egypt, Minya, , Egypt

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

NCT ID: NCT06219941

This clinical trial is studying a new treatment called AZD0901 for patients with advanced solid tumors that express a protein known as Claudin18.2. The trial aims to find out how safe and effective...

Recruiting

Phase: PHASE2 Type: interventional Locations: Barcelona, , Spain, Houston, Texas, United States +42 more

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

NCT ID: NCT06831136

This clinical trial is exploring a new treatment approach for patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer that cannot be surgic...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Study for AZD4360 in Participants With Advanced Solid Tumours

NCT ID: NCT06921928

This clinical trial is investigating a new treatment called AZD4360 for adults with advanced solid tumors, specifically those diagnosed with gastric cancer, gastroesophageal junction cancer, biliar...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Houston, Texas, United States +10 more

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

NCT ID: NCT07024615

This clinical trial is studying a new treatment called ASP2138 for people with a type of pancreatic cancer that can be removed with surgery. Some pancreatic tumors have a protein called Claudin 18....

Not yet recruiting

Phase: PHASE1 Type: interventional

Pancreatic Cancer Early Detection Consortium

NCT ID: NCT04970056

The Pancreatic Cancer Early Detection Consortium (PRECEDE) is a research study aimed at finding ways to detect pancreatic ductal adenocarcinoma (PDAC) earlier and prevent it from developing. The st...

Recruiting

Type: observational Locations: Kansas City, Kansas, United States, Ann Arbor, Michigan, United States +68 more

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

NCT ID: NCT06005493

This clinical trial is investigating a new treatment called AZD5863 for adults with advanced cancer, specifically focusing on types like gastric cancer, gastro-esophageal junction cancer, pancreati...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Dundee, , United Kingdom +23 more

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT ID: NCT05482893

The TWINPEAK Study is a clinical trial investigating a new treatment called PT886 for patients with advanced forms of gastric cancer, gastroesophageal junction cancer, or pancreatic cancer that can...

Recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, Louisville, Kentucky, United States +9 more

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT ID: NCT06305247

This clinical trial is studying a new medication called IPN01194 to see how safe and effective it is for adults with advanced solid tumors. These tumors can come from various cancers, including mel...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Nashville, Tennessee, United States +10 more

Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06122480

This clinical trial, called PHOLIPANC, is investigating the potential benefits of surgically removing pancreatic cancer that has spread to either the liver or lungs in patients who have already rec...

Recruiting

Phase: NA Type: interventional Locations: Baltimore, Maryland, United States

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT ID: NCT04657068

This clinical trial is investigating a new drug called ART0380 for treating advanced or metastatic solid tumors, including types of ovarian cancer. The main goals are to find out the safest dose of...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Denver, Colorado, United States +68 more

A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT ID: NCT05851924

This clinical trial is investigating a new treatment approach for patients with pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer that can be challenging to treat. The study will...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +5 more

A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT04477343

This clinical trial is investigating the safety and tolerability of a new treatment called SX-682 when combined with nivolumab, a medication that helps the immune system fight cancer. The study foc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, New York, United States, Rochester, New York, United States

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

NCT ID: NCT06122896

This clinical trial is exploring a new way to detect pancreatic cancer early in people who are at high risk. Researchers want to see if adding blood tests and a review of symptoms to the usual scre...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +1 more

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

NCT ID: NCT05634720

This clinical trial is exploring a new treatment approach for patients with localized pancreatic cancer, specifically a type called pancreatic ductal adenocarcinoma. The study is testing a single d...

Recruiting

Phase: PHASE4 Type: interventional Locations: Durham, North Carolina, United States

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

NCT ID: NCT06287463

This clinical trial is studying a new medication called DCC-3084 to see how well it works for people with advanced cancers that have specific genetic changes in the MAPK pathway, which can drive ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Los Angeles, California, United States +7 more

Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT ID: NCT06710756

This clinical trial is studying a new treatment called Lead-212 PSV359 for patients with certain types of solid tumors, including pancreatic, gastric, esophageal, colorectal, ovarian, and head and ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Omaha, Nebraska, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions